223 related articles for article (PubMed ID: 27981514)
1. Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma.
Ferraù F; Spagnolo F; Cotta OR; Cannavò L; Alibrandi A; Russo GT; Aversa T; Trimarchi F; Cannavò S
Endocrine; 2017 Nov; 58(2):295-302. PubMed ID: 27981514
[TBL] [Abstract][Full Text] [Related]
2. LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY.
Xie X; Li Q; Zhang L; Ren W
Endocr Pract; 2018 Jan; 24(1):33-39. PubMed ID: 29144802
[TBL] [Abstract][Full Text] [Related]
3. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study.
Smith JD; Borel AL; Nazare JA; Haffner SM; Balkau B; Ross R; Massien C; Alméras N; Després JP
J Clin Endocrinol Metab; 2012 May; 97(5):1517-25. PubMed ID: 22337910
[TBL] [Abstract][Full Text] [Related]
4. Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: contribution of improved cardiorespiratory fitness vs. weight loss.
Borel AL; Nazare JA; Baillot A; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E273-E281. PubMed ID: 28028035
[TBL] [Abstract][Full Text] [Related]
5. Visceral adiposity index and triglyceride/high-density lipoprotein cholesterol ratio in hypogonadism.
Haymana C; Sonmez A; Aydogdu A; Tapan S; Basaran Y; Meric C; Baskoy K; Dinc M; Yazici M; Taslipinar A; Barcin C; Yilmaz MI; Bolu E; Azal O
Arch Endocrinol Metab; 2017; 61(3):282-287. PubMed ID: 28225990
[TBL] [Abstract][Full Text] [Related]
6. Pasireotide treatment reduces cardiometabolic risk in Cushing's disease patients: an Italian, multicenter study.
Albani A; Ferraù F; Ciresi A; Pivonello R; Scaroni C; Iacuaniello D; Zilio M; Guarnotta V; Alibrandi A; Messina E; Boscaro M; Giordano C; Colao A; Cannavo S
Endocrine; 2018 Jul; 61(1):118-124. PubMed ID: 29383677
[TBL] [Abstract][Full Text] [Related]
7. Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk.
Boulet MM; Chevrier G; Grenier-Larouche T; Pelletier M; Nadeau M; Scarpa J; Prehn C; Marette A; Adamski J; Tchernof A
Am J Physiol Endocrinol Metab; 2015 Oct; 309(8):E736-46. PubMed ID: 26306599
[TBL] [Abstract][Full Text] [Related]
8. Identification of cardiometabolic risk: visceral adiposity index versus triglyceride/HDL cholesterol ratio.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Maciel PM; Reaven GM
Am J Med; 2014 Feb; 127(2):152-7. PubMed ID: 24462013
[TBL] [Abstract][Full Text] [Related]
9. Metabolic consequences of adipose tissue dysfunction and not adiposity per se increase the risk of cardiovascular events and mortality in patients with type 2 diabetes.
Franssens BT; Westerink J; van der Graaf Y; Nathoe HM; Visseren FLJ;
Int J Cardiol; 2016 Nov; 222():72-77. PubMed ID: 27458826
[TBL] [Abstract][Full Text] [Related]
10. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease.
Petta S; Amato MC; Di Marco V; Cammà C; Pizzolanti G; Barcellona MR; Cabibi D; Galluzzo A; Sinagra D; Giordano C; Craxì A
Aliment Pharmacol Ther; 2012 Jan; 35(2):238-47. PubMed ID: 22117531
[TBL] [Abstract][Full Text] [Related]
11. Visceral Adiposity Index as an Independent Marker of Subclinical Atherosclerosis in Individuals Prone to Diabetes Mellitus.
Randrianarisoa E; Lehn-Stefan A; Hieronimus A; Rietig R; Fritsche A; Machann J; Balletshofer B; Häring HU; Stefan N; Rittig K
J Atheroscler Thromb; 2019 Sep; 26(9):821-834. PubMed ID: 30787215
[TBL] [Abstract][Full Text] [Related]
12. Visceral Adiposity Index as an Indicator of Cardiometabolic Risk in Patients with Congenital Adrenal Hyperplasia.
Kara Z; Demir AN; Sulu C; Durcan E; Uysal S; Turan H; Özkaya HM; Evliyaoğlu SO; Ercan O; Gönen MS
Metab Syndr Relat Disord; 2023 Feb; 21(1):35-40. PubMed ID: 36576499
[No Abstract] [Full Text] [Related]
13. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk.
Amato MC; Giordano C; Galia M; Criscimanna A; Vitabile S; Midiri M; Galluzzo A;
Diabetes Care; 2010 Apr; 33(4):920-2. PubMed ID: 20067971
[TBL] [Abstract][Full Text] [Related]
14. Childhood Craniopharyngioma: A 22-Year Challenging Follow-Up in a Single Center.
Tosta-Hernandez PDC; Siviero-Miachon AA; da Silva NS; Cappellano A; Pinheiro MM; Spinola-Castro AM
Horm Metab Res; 2018 Sep; 50(9):675-682. PubMed ID: 29959763
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy.
Holmer H; Ekman B; Björk J; Nordstöm CH; Popovic V; Siversson A; Erfurth EM
Eur J Endocrinol; 2009 Nov; 161(5):671-9. PubMed ID: 19667040
[TBL] [Abstract][Full Text] [Related]
16. Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study.
Neeland IJ; Singh S; McGuire DK; Vega GL; Roddy T; Reilly DF; Castro-Perez J; Kozlitina J; Scherer PE
Diabetologia; 2018 Dec; 61(12):2570-2579. PubMed ID: 30159588
[TBL] [Abstract][Full Text] [Related]
17. The visceral adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency.
Ciresi A; Radellini S; Guarnotta V; Giordano C
Endocrine; 2017 Jun; 56(3):579-588. PubMed ID: 27520559
[TBL] [Abstract][Full Text] [Related]
18. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.
Mlinar B; Marc J; Jensterle M; Bokal EV; Jerin A; Pfeifer M
J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):127-32. PubMed ID: 21147223
[TBL] [Abstract][Full Text] [Related]
19. Visceral adiposity index and 10-year cardiovascular disease incidence: The ATTICA study.
Kouli GM; Panagiotakos DB; Kyrou I; Georgousopoulou EN; Chrysohoou C; Tsigos C; Tousoulis D; Pitsavos C
Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):881-889. PubMed ID: 28851556
[TBL] [Abstract][Full Text] [Related]
20. Adult weight change in relation to visceral fat and liver fat at middle age: The Netherlands epidemiology of obesity study.
Verkouter I; Noordam R; de Roos A; Lamb HJ; Rosendaal FR; van Heemst D; de Mutsert R
Int J Obes (Lond); 2019 Apr; 43(4):790-799. PubMed ID: 30026588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
